Internal Medicine, Cardiovascular Disease · Glendale, CA
NPI
1477536738
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
660 W Broadway
Glendale, CA, 91204
Phone (818) 243-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$675K
22,524 services
Medicare patients, 2024
1,427
Average age 75
Drug cost, 2024
$4.0M
19,693 prescriptions
Company payments, 2025
$649
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haroutioun D Mesrobian was code 99213 (office e&m - established), 2,834 times for 1,129 patients. In total Haroutioun D Mesrobian billed 22,524 services in 52 codes, and Medicare paid $675K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,834 | 1,129 | $73.11 | $207K |
| 93000 Electrocardiogram | Office | 2,589 | 1,111 | $11.81 | $31K |
| 36415 Venipuncture Blood Collection | Office | 1,029 | 788 | $8.65 | $8,901 |
| 93306 Echocardiography (TTE/TEE) | Office | 940 | 900 | $171.30 | $161K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 761 | 191 | $6.84 | $5,202 |
| 80061 Clinical Chemistry | Office | 747 | 628 | $13.12 | $9,801 |
| 85025 Blood Count | Office | 725 | 624 | $7.61 | $5,517 |
| 84481 Clinical Chemistry | Office | 715 | 614 | $16.60 | $12K |
| 84443 Clinical Chemistry | Office | 715 | 614 | $16.46 | $12K |
| 83036 Blood Count | Office | 715 | 616 | $9.52 | $6,807 |
| 84439 Clinical Chemistry | Office | 715 | 614 | $8.84 | $6,321 |
| 82746 Clinical Chemistry | Office | 714 | 615 | $14.41 | $10K |
| 83540 Clinical Chemistry | Office | 714 | 615 | $6.34 | $4,527 |
| 83550 Clinical Chemistry | Office | 714 | 615 | $8.57 | $6,119 |
| 86141 Clinical Chemistry | Office | 714 | 615 | $12.69 | $9,061 |
By year: 2022 $497K for 8,433 services; 2023 $591K for 13,741 services; 2024 $675K for 22,524 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,029 | 788 | $8.65 | $8,901 |
| 80061 Clinical Chemistry | 747 | 628 | $13.12 | $9,801 |
| 85025 Blood Count | 725 | 624 | $7.61 | $5,517 |
| 83036 Blood Count | 715 | 616 | $9.52 | $6,807 |
| 84439 Clinical Chemistry | 715 | 614 | $8.84 | $6,321 |
| 84443 Clinical Chemistry | 715 | 614 | $16.46 | $12K |
| 84481 Clinical Chemistry | 715 | 614 | $16.60 | $12K |
| 83540 Clinical Chemistry | 714 | 615 | $6.34 | $4,527 |
| 83550 Clinical Chemistry | 714 | 615 | $8.57 | $6,119 |
| 86141 Clinical Chemistry | 714 | 615 | $12.69 | $9,061 |
Medicare prescription drug claims, 2024
In 2024, the drug Haroutioun D Mesrobian prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 2,531 prescriptions and refills. In total Haroutioun D Mesrobian wrote 19,693 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 2,531 | 2,757 | 301 | $1.8M |
| Carvedilol Generic | 1,503 | 1,704 | 191 | $3,534 |
| Ezetimibe Generic | 1,385 | 1,620 | 190 | $9,909 |
| Rosuvastatin Calcium Generic | 1,329 | 1,583 | 182 | $5,074 |
| Amlodipine Besylate Generic | 1,120 | 1,327 | 160 | $1,173 |
| Jardiance Empagliflozin | 855 | 906 | 109 | $525K |
| Ranolazine Er Ranolazine | 737 | 802 | 87 | $30K |
| Eliquis Apixaban | 533 | 559 | 67 | $325K |
| Atorvastatin Calcium Generic | 525 | 627 | 76 | $1,187 |
| Farxiga Dapagliflozin Propanediol | 522 | 535 | 88 | $302K |
| Xarelto Rivaroxaban | 454 | 505 | 58 | $286K |
| Metoprolol Succinate Generic | 452 | 543 | 69 | $2,275 |
| Colchicine Generic | 449 | 476 | 130 | $9,039 |
| Hydrochlorothiazide Generic | 443 | 522 | 69 | $756 |
| Furosemide Generic | 431 | 501 | 66 | $579 |
Brand drugs: - claims; generic drugs: 13,432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haroutioun D Mesrobian $649 ($649 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $323.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.